[1]
Lu, D.Y. Important factors for controlling Ebola epidemics. Advanced Techniques in Biology & Medicine, 2014, 2, e103.
[2]
Labrijn, A.F.; Parren, P.W. Hitting Ebola, to the power of two. Science, 2016, 354(6310), 284-285.
[3]
Lu, D.Y.; Lu, T.R. Further suggestions for controlling Ebola epidemics. Int J Adv Biol Sci Engineering, 2015, 2, 57-59.
[4]
Lu, D.Y.; Lu, T.R.; Wu, H.Y.; Ding, J. Future perspectives for controlling Ebola epidemics. Metabolomics, 2015, 5, e135.
[5]
Gire, S.K.; Goba, A.; Andersen, K.G.; Sealfon, R.S.; Park, D.J.; Kanneh, L.; Jalloh, S.; Momoh, M.; Fullah, M.; Dudas, G.; Wohl, S.; Moses, L.M.; Yozwiak, N.L.; Winnicki, S.; Matranga, C.B.; Malboeuf, C.M.; Qu, J.; Gladden, A.D.; Schaffner, S.F.; Yang, X.; Jiang, P.P.; Nekoui, M.; Colubri, A.; Coomber, M.R.; Fonnie, M.; Moigboi, A.; Gbakie, M.; Kamara, F.K.; Tucker, V.; Konuwa, E.; Saffa, S.; Sellu, J.; Jalloh, A.A.; Kovoma, A.; Koninga, J.; Mustapha, I.; Kargbo, K.; Foday, M.; Yillah, M.; Kanneh, F.; Robert, W.; Massally, J.L.; Chapman, S.B.; Bochicchio, J.; Murphy, C.; Nusbaum, C.; Young, S.; Birren, B.W.; Grant, D.S.; Scheiffelin, J.S.; Lander, E.S.; Happi, C.; Gevao, S.M.; Gnirke, A.; Rambaut, A.; Garry, R.F.; Khan, S.H.; Sabeti, P.C. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science, 2014, 345(6202), 1369-1372.
[6]
Lu, D.Y.; Che, J.Y.; Lu, T.R.; Ding, J. Ebola origin and therapies. Metabolomics, 2015, 5, e138.
[7]
Lu, D.Y.; Wu, H.Y.; Lu, Y.; Lu, T.R. The origins of HIV. Adv. Pharmacoepidemiol. Drug Saf., 2015, 4, e136.
[8]
Lu, D.Y.; Wu, H.Y.; Yarla, N.S.; Lu, Y. The origins of HIV: A promising medical topic. HIV: Current Res., 2016, 1(2), 116.
[9]
Abbott, A.; Pearson, H. Fear of human pandemic grows as bird flu sweeps through Asia. Nature, 2004, 427(6974), 472-473.
[10]
Webster, R.; Hulse, D. Controlling avian flu at the source. Nature, 2005, 435(7041), 415-416.
[11]
Radriguez-Morales, A. Challenges for fish food-borne parasitic zoonotic diseases. Recent Patents Anti-Infect. Drug Disc., 2015, 10, 3-5.
[12]
Chowdhury, F.R.; Basher, A.; Amin, M.R.; Hassan, N.; Patwary, M.I. Rabies in South Asia: fighting for elimination. Recent Pat Antiinfect Drug Discov, 2015, 10(1), 30-34.
[13]
Goldberg, D.E.; Siliciano, R.F.; Jacobs, W.R. Jr Outwitting evolution: fighting drug-resistant TB, malaria, and HIV. Cell, 2012, 148(6), 1271-1283.
[14]
Pennisi, E. Microbiology. Contamination plagues some microbiome studies. Science, 2014, 346(6211), 801.
[15]
Schröder, A.R.W.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J.R.; Bushman, F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 2002, 110(4), 521-529.
[16]
Lu, D.Y.; Ding, J. Sequencing the whole genome of infected human cells obtained from diseased patients- proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases. Med. Hypotheses, 2007, 68(4), 826-827.
[17]
Lu, D.Y.; Ding, J. AIDS and human genome studies, from a hypothesis to systematic approaches. Med. Hypotheses, 2007, 69(3), 695.
[18]
Lu, D.Y.; Lu, T.R.; Che, J.Y.; Wu, H.Y.; Xu, B. New perspectives of HIV/AIDS therapy study. Recent Pat Antiinfect Drug Discov, 2014, 9(2), 112-120.
[19]
Collins, F. Has the revolution arrived? Nature, 2010, 464(7289), 674-675.
[20]
Venter, J.C. Multiple personal genomes await. Nature, 2010, 464(7289), 676-677.
[21]
Lander, E.S. Initial impact of the sequencing of the human genome. Nature, 2011, 470(7333), 187-197.
[22]
Maher, B. Human genetics: Genomes on prescription. Nature, 2011, 478(7367), 22-24.
[23]
Lu, D.Y.; Lu, T.R. Mathematics or physics-majored students on the biomedical fields, insiders or outsiders. Metabolomics, 2015, 5(4), e142.
[24]
Lu, D.Y.; Wu, H.Y.; Lu, T.R.; Che, J.Y.; Lu, Y. Updating biomedical studies by recruiting more mathematics or physics-majored talents. Metabolomics, 2016, 6(2), e148.
[25]
Yoshida, H; Taoda, Y; Johns, BA; Kawasuji, TND Synthesis of carbamoyl pyridine HIV integrase inhibitors and intermediates. US2014094605 A1, 2014.
[26]
Oleman, PJ; Embrey, M; Hartingh, TJ; Powell, D; Raheem, IT; Chang, RK; Schreier, J; Sisko, J; Steele, T Walji, A Substituted naphthyridinedione derivatives as HIV integrase inhibitors., WO2014018449 A1, 2014.
[27]
Huang, W.; Petropoulos, C.J. Methods and compositions for determining virus susceptibility to integrase inhibitors. E, 2014, A1, 2678453.
[28]
Engelman, A. AIDS/HIV. A reversal of fortune in HIV-1 integration. Science, 2007, 316(5833), 1855-1857.
[29]
Cox, D.B.T.; Platt, R.J.; Zhang, F. Therapeutic genome editing: Prospects and challenges. Nat. Med., 2015, 21(2), 121-131.
[30]
Kupferschmidt, K. INFECTIOUS DISEASES. Surviving Ebola survival. Science, 2015, 348(6242), 1406-1407.
[31]
Cohen, J.; Kupferschmidt, K. Infectious Diseases. Ebola vaccine trials raise ethical issues. Science, 2014, 346(6207), 289-290.
[32]
Cohen, J.; Enserink, M. CLINICAL TRIALS. Ebola vaccines face daunting path to approval. Science, 2015, 349(6254), 1272-1273.
[34]
Lu, D.Y.; Lu, T.R.; Wu, H.Y. Avian flu, pathogenesis and therapy. Antiinfect. Agents, 2012, 10, 124-129.
[35]
Cardile, A.P.; Mayers, D.L.; Bavari, S. Current status of chemically synthesized inhibitors of Ebola virus. Recent Pat Antiinfect Drug Discov, 2014, 9(2), 97-103.
[36]
Wadman, M. Vaccines on trial. Science, 2017, 356(6336), 370-373.
[37]
Kupferschmidt, K. The science of persuasion. Science, 2017, 356(6336), 366-369.
[38]
Lu, D.Y.; Wu, H.Y.; Lu, T.R.; Xu, B.; Ding, J. HIV vaccination, is breakthrough underway? Rev. Recent Clin. Trials, 2016, 11(2), 145-151.
[39]
Lu, D.Y.; Wu, H.Y.; Ding, J.; Sastry, N.; Lu, T.R. HIV vaccine for prevention and cure, a mission possible. Rev. Recent Clin. Trials, 2016, 11(4), 290-296.
[40]
Lu, D.Y.; Lu, T.R.; Lu, Y.; Sastry, N.; Wu, H.Y. Discover natural chemical drugs in modern medicines. Metabolomics, 2016, 6(3), 181.
[41]
Zhang, Z.J. (张仲景). Cold factors and treatments (伤寒论); People’s Medical and Public Health Publication: Beijing, PR China, 2005.
[42]
Rasmussen, A.L.; Okumura, A.; Ferris, M.T.; Green, R.; Feldmann, F.; Kelly, S.M.; Scott, D.P.; Safronetz, D.; Haddock, E.; LaCasse, R.; Thomas, M.J.; Sova, P.; Carter, V.S.; Weiss, J.M.; Miller, D.R.; Shaw, G.D.; Korth, M.J.; Heise, M.T.; Baric, R.S.; de Villena, F.P.; Feldmann, H.; Katze, M.G. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science, 2014, 346(6212), 987-991.
[43]
Pomerantz, R.J.; Horn, D.L. Twenty years of therapy for HIV-1 infection. Nat. Med., 2003, 9(7), 867-873.
[44]
Lu, D.Y.; Lu, T.R. High active antiretroviral therapy for HIV/AIDS, progresses and drawback. Adv. Pharmacoepidemiol. Drug Saf., 2012, 1, e115.
[45]
Lu, D.Y.; Lu, T.R.; Wu, H.Y.; Che, J.Y. Challenges for HIV/AIDS therapy. Adv. Pharmacoepidemiol. Drug Saf., 2013, 2, e120.
[46]
Lu, D.Y.; Lu, T.R.; Che, J.Y.; Ding, J.; Xu, B.; Wu, H.Y. Advances and shortcoming of HIV/AIDS therapy. Innovations in Pharmaceuticals and Pharmacotherapy., 2015, 3, 511-518.
[47]
Lu, D.Y.; Wu, H.Y.; Yarla, N.S.; Xu, B.; Ding, J.; Lu, T.R. HAART in HIV/AIDS treatments, future trends. Infect. Disord. Drug Targets, 2018, 18(1), 15-22.
[48]
Ali, I.; Saleem, K.; Uddin, R.; Haque, A.; El-Azzouny, A. Natural products: human friendly anti-cancer medications. Egypt Pharm J, 2010, 9, 133-179.
[49]
Prasad, S.; Tyagi, A.K. Traditional Medicine, the goldmine for modern drugs. Adv Tech Biol Med., 2015, 3(1), e108.
[50]
Lu, D.Y.; Lu, T.R.; Wu, H.Y. Zika therapy by traditional Chinese medicine, a new proposal. Adv Pharmacol Clinical Trial, 2016, 1(1), 103.
[51]
Liu, D.F.; Liu, Y.L.; Chen, H.; Zeng, W.L.; Wen, X.M.; Ye, Q.; Li, L.H.; Zhou, X.F. Evaluation on the curative effect and safety of Chinese traditional medicine in treatment of mild a/hH1N1 influenza in sichuan area. Mod. Prev. Med., 2011, 38(2), 338-343.
[52]
Zhou, Ho; Tao, LT; Xu, HC; Jiang, YG; Deng, YQ; Luo, Y Lu, CJ Discussion on Laws of Traditional
Chinese Medical Treat-ment of H1N1 Influenza
Based on Cohort Study. World Science and Technology/
Modernization of Traditional Chinese Medicine
and Materia Medica., 2011, 13, 777-82.
[53]
Rumschlag-Booms, E.; Zhang, H.; Soejarto, D.D.; Fong, H.H.S.; Rong, L. Development of an antiviral screening protocol: One-stone-two-birds. J. Antivir. Antiretrovir., 2011, 3, 8-10.
[54]
Li, Y.H.; Yan, Q.B.; Yu, K.Z.; Tong, H.M.; Sun, Y. Study of the compound Chinese medicine against the anti-avian influenza virus. Zhongguo Nong Ye Ke Xue, 2008, 41, 1511-1518.
[55]
Lu, D.Y.; Lu, T.R.; Wu, H.Y. Treatment of influenza virus infections with Chinese medicine. Adv. Pharmacoepidemiol. Drug Saf., 2012, 1, e104.
[57]
Lu, D.Y.; Lu, T.R.; Wu, H.Y. Treatment of influenza virus infections with Chinese medicine. Adv. Pharmacoepidemiol. Drug Saf., 2012, 1, e104.
59
6